Medtronic
Search results
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [4]
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.
Get the latest Edwards Lifesciences Corp (EW) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Edwards Lifesciences has an overall rating of 4.1 out of 5, based on over 1,574 reviews left anonymously by employees. 80% of employees would recommend working at Edwards Lifesciences to a friend and 75% have a positive outlook for the business. This rating has been stable over the past 12 months.
Jun 28, 2012 · Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart...
Feb 2, 2024 · Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).
Jun 3, 2024 · BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader. Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating ...
